Trial intelligence / Profile preview

AccuPAP vs Standard Nebulizer in Pediatric Acute Asthma

NCT02458482Withdrawn

Sponsor
Vanderbilt University Medical Center
Start
Jul 2015
Primary completion
Nov 2020
Countries
1
01

Overview

Randomised, single-blind trial in asthma (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoint: Acute Asthma Intensity Research Score at 2 hours. Planned start Jul 2015; status: withdrawn.

02

Conditions

asthma

Beyond the preview

Go deeper on NCT02458482.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02458482.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call